Preparation and characterization of the β-cyclodextrin inclusion complex with sulfadimethoxine

Acta Poloniae Pharmaceutica - Drug Research

Volumn 53, Issue 5, 1996, Pages 341-347

  Szafran, Barbara ^a   Pawlaczyk, Jan ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

cyclodextrin complex; Freeze drying; IR and 13C NMR complexation effect; Kneading; Sulfadimethoxine; Thermal analysis; UV spectroscopy

Indexed keywords

BETA CYCLODEXTRIN; DIMETHYL SULFOXIDE; SULFADIMETHOXINE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL ANALYSIS; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; FREEZE DRYING; INFRARED SPECTROMETRY; THERMAL ANALYSIS; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION;

EID: 0029961419     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Namor A.F.D., Tanaka D.A.P., Regueira L.N., Orellana I.G.: J. Chem. Soc. Faraday Trans. 88, 1665 (1992).
2. Mura P., Bettinetti G., Melani F., Manderioli A.: Eur. J. Pharm. Sci. 3, 347 (1995).
3. Ammar H.O., Ghorab M., El-Nahhas S.A., Omar S.M., Ghorab M.M.: Pharmazie 51, 42 (1996).
4. Lutka A., Pawlaczyk J.: Acta Polon. Pharm. - Drug Res. 52, 379 (1995).
5. Mielcarek J.: Acta Polon. Pharm. - Drug Res. 51, 443 (1994).
6. Jeffrey G.A., Saenger W.: Hydrogen Bonding in Biological Structres p. 309, Springer-Verlag Berlin, Heidelberg, New York 1991.
7. Szejtli J.: Cyclodextrins and Their Inclusion Complexes, Academia Kiado, Budapest 1982.
8. Wenz G.: Angew. Chem. Int. Ed. Engl. 33, 803 (1994).
9. Breslow R.: Acc. Chem. Res. 28, 146 (1995).
10. Kuroda Y., Suzuki Y., He J., Kawabata T., Shibukawa A., Wada H., Fujima H., Go-oh Y., Imai E., Nakagawa T.: J. Chem. Soc. Perkin Trans 2. 1749 (1995).
11. Helm H., Andersen A., Müller B.W., Waaler T.: Acta Pharm. Nord. 4, 313 (1992).
12. Frömming K-H., Fridrich R., Mehnert W.: Eur. J. Pharm. Biopharm. 39, 148 (1993).
13. Szafran B., Pawlaczyk J.: J. Incl. Phenom. in press.
14. Uekama K., Hirayama F., Otagiri M., Otagiri Y., Ikeda k.: Chem. Pharm. Bull. 26, 1162 (1978).
15. Wang M., Ueda H., Nagai T.: Drug Develop. Ind. Pharm. 16, 571 (1990).
16. Caira M.R., Griffith V.J., Nassimbeni L.R.: J. Incl. Phenom. 17, 187 (1994).
17. Munoz de la Pena A., Salinas F., Durun-Meras I., Moreno M.D.: Anal. Lett. 27, 1893 (1994).
18. Szafran B., Pawlaczyk J.: Acta Polon. Pharm. - Drug Res. 52, 387 (1995).
19. Lin S-Z., Wouessidjewe D., Poelman M-Ch., Duchêne D.: Int. J.Pharm. 69, 211 (1991).
20. Nozawa Y., Mizumoto T., Higashide F.: Pharm. Acta Helv. 61, 337 (1986).
21. Rahman Atta-ur: One and Two Dimensional NMR Spectroscopy, Elsevier, Amsterdam 1989.
22. Higuchi T., Connors K.A.: Adv. Anal. Chem. Instr., Reilley Ch.N, Ed., Vol. 4, p. 117, Chapel Hill N.C. 1965.
23. Senger W.: Angew. Chem. Int. Ed. Engl. 19, 344 (1980).
24. Alves O.L., Fonseca S.F.: J. Incl. Phenom., 7, 589 (1989).
25. Ewing D.F.: Org. Magn. Reson., 12, 499 (1979).
26. Katritzky A.R.: Handbook of Heterocyclic Chemistry, p. 23, Pergamon Press, Oxford 1985.
27. Duchêne D., Wouessidjewe D.: Acta Pharm. Technol. 36, 1 (1990).